• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NEUROPACE, INC. NEUROPACE RNS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NEUROPACE, INC. NEUROPACE RNS SYSTEM Back to Search Results
Model Number 1007603
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abscess (1690); Unspecified Infection (1930)
Event Date 07/10/2016
Event Type  Injury  
Manufacturer Narrative
(b)(4).Device not returned.
 
Event Description
(b)(6) 2016 patient was implanted with the rns system including the rns neurostimulator (sn (b)(4)) and two cortical strip leads ( sn (b)(4)).The leads were placed in the right frontal parietal region of the brain.(b)(6) 2016 the patient presented with symptoms.(b)(6) 2016 patient had a system explant due to a brain abscess.Abscess was located in the epidural and subdural space.The patient was treated with iv antibiotics followed by oral antibiotics.The rns system was programmed for detection but not treatment.Last ecog was synchronized on (b)(6) 2016.The rns system was discarded.The abscess occurred approximately three months after implant.Medical affairs manager, (b)(4) spoke with (b)(6), md regarding adverse event.Dr.(b)(6) stated that the patient had a tumor resected years before and developed an osteomyelitis resulting in placement of a cranioplast plate.This may have put the patient in a higher risk category for recurrent infection.Dr.(b)(6) stated that the patient presented with a (1) cm boggy area under a portion of the incision line.There was minimal drainage at the site.When the patient underwent surgical exploration of the area, there was copious amounts of pus above and under the cranioplast plate along with pus both in the epidural and subdural space.Patient did undergo phase 2 monitoring which lasted 7 days prior to implant of the rns system.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEUROPACE RNS SYSTEM
Type of Device
NEUROPACE RNS SYSTEM
Manufacturer (Section D)
NEUROPACE, INC.
455 n. bernardo ave.
mountain view CA 94043
Manufacturer (Section G)
NEUROPACE, INC.
455 n. bernardo ave.
mountain view CA 94043
Manufacturer Contact
ramona gonis
455 n. bernardo ave.
mountain view, CA 94043
6502382788
MDR Report Key5855305
MDR Text Key51443667
Report Number3004426659-2016-00019
Device Sequence Number1
Product Code PFN
UDI-Device Identifier00855547005120
UDI-Public010085554700512017160526
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100026
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 08/08/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/08/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Model Number1007603
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/11/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age46 YR
-
-